Replies to post #35523 on Sunshine Biopharma Inc (SBFM)

[skichic]

Because they just filed for the DEL 10 days ago! Get real!


MostlMONTREAL, QC / ACCESSWIRE / June 19, 2017 / Sunshine Biopharma Inc. (OTC PINK: SBFM), a fully integrated pharmaceutical company offering generic and proprietary drugs for the treatment of cancer and other acute and chronic indications, is pleased to announce that it has filed an application for a Drug Establishment License ("DEL") with Health Canada, the Canadian equivalent of the FDA in the United States. Obtaining a DEL is the first step in the certification process of a company to be able to handle drugs, including manufacturing, storage, tracking and distribution. Following the procurement of a DEL, the Company will apply for Drug Identification Numbers ("DIN's") for its pharmaceutical products which are currently comprised of the following:

- Anastrozole (brand name Arimidex® by AstraZenica) for treatment of Breast Cancer

- Letrozole (brand name Femara® by Novartis) for treatment of Breast Cancer

- Bicalutamide (brand name Casodex® by AstraZenica) for treatment of Prostate Cancer

- Finasteride (brand name Propecia® by Merck) for treatment of BPH (Benign Prostatic Hyperplasia)

Worldwide sales of the brand name version of these products as reported by the respective owner of the registered trademark are approximately as follows:



- Arimidex® $232M in 2016

- Femara® $380M in 2014

- Casodex® $247M in 2016

- Propecia® $183M in 2015y

[General Grievous]

Great day here!